A214610 Stock Overview
Provides on-site diagnostic systems based on Lab-on-a-Chip technology.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
MiCo BioMed Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩1,387.00 |
52 Week High | ₩5,608.44 |
52 Week Low | ₩1,354.00 |
Beta | 0.45 |
1 Month Change | -3.68% |
3 Month Change | -20.24% |
1 Year Change | -68.30% |
3 Year Change | -87.05% |
5 Year Change | -78.10% |
Change since IPO | -84.07% |
Recent News & Updates
Shareholder Returns
A214610 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -3.6% | 4.6% | -1.7% |
1Y | -68.3% | 3.7% | 0.6% |
Return vs Industry: A214610 underperformed the KR Medical Equipment industry which returned 3.7% over the past year.
Return vs Market: A214610 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
A214610 volatility | |
---|---|
A214610 Average Weekly Movement | 6.3% |
Medical Equipment Industry Average Movement | 6.2% |
Market Average Movement | 5.1% |
10% most volatile stocks in KR Market | 11.3% |
10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A214610's share price has been volatile over the past 3 months.
Volatility Over Time: A214610's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 88 | Young S Hong | www.micobiomed.com |
MiCo BioMed Co., Ltd. provides on-site diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) System, a device which include, membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; and LabChip, sample tube, and pre-filtering column. It also provides biological chemistry products, including VERI-Q Multi, a cholesterol diagnostic product; VERI-Q RED, a hemoglobin monitoring system; Healthy- Q Life, a cholesterol monitoring system; Healthy- Q Multi, a multifunctional monitoring system; and Healthy- Q Balance Pro.
MiCo BioMed Co., Ltd. Fundamentals Summary
A214610 fundamental statistics | |
---|---|
Market cap | ₩60.42b |
Earnings (TTM) | -₩25.77b |
Revenue (TTM) | ₩5.37b |
11.3x
P/S Ratio-2.3x
P/E RatioIs A214610 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A214610 income statement (TTM) | |
---|---|
Revenue | ₩5.37b |
Cost of Revenue | ₩12.34b |
Gross Profit | -₩6.97b |
Other Expenses | ₩18.80b |
Earnings | -₩25.77b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -591.70 |
Gross Margin | -129.88% |
Net Profit Margin | -480.20% |
Debt/Equity Ratio | 28.7% |
How did A214610 perform over the long term?
See historical performance and comparison